Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Shulman

Showing results (31-40 of 282) with videos related to

Pageof 29
Sort By:
Journal of Oncology Practice|April 20, 2013
Improving electronic oral chemotherapy prescription: can we build a safer system?Saul N Weingart, Thea Mattsson, Junya Zhu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-upG P Canellos, J Gollub, D Neuberg, et al.
Cancer|January 15, 1994
Bone marrow dysplasia in patients with newly diagnosed acute myelogenous leukemia does not correlate with history of myelodysplasia or with remission rate and survivalK K Ballen, D G Gilliland, L A Kalish, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Cancer Care and Control as a Human Right: Recognizing Global Oncology as an Academic FieldAlexandru E Eniu, Yehoda M Martei, Edward L Trimble, et al.
JAMA Oncology|August 8, 2020
Applying Lessons Learned From Low-Resource Settings to Prioritize Cancer Care in a PandemicRebecca J DeBoer, Temidayo A Fadelu, Lawrence N Shulman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
A Survey of the National Comprehensive Cancer Network on Approaches Toward Addressing Patients' Transportation InsecurityKrisda H Chaiyachati, Diana Krause, Jessica Sugalski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot studyM A Shipp, D Neuberg, M Janicek, et al.
JAMA Network Open|October 24, 2024
Racial Disparities in Receipt of Guideline-Concordant Care in Older Adults With Early Breast CancerBrenda S Castillo, Taussia Boadi, Xiaoyan Han, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Low-dose total body irradiation and G-CSF without hematopoietic stem cell support in the treatment of relapsed or refractory acute myelogenous leukemia (AML), or AML in second or subsequent remissionL N Shulman, N J Tarbell, E Storen, et al.
Malawi Medical Journal : the Journal of Medical Association of Malawi|December 21, 2013
Biopsy case mix and diagnostic yield at a Malawian central hospitalP Mtonga, L Masamba, D Milner, et al.
Pageof 29

Showing results (31-40 of 282) with videos related to

Sort By:
Pageof 29
Journal of Oncology Practice|April 20, 2013
Improving electronic oral chemotherapy prescription: can we build a safer system?Saul N Weingart, Thea Mattsson, Junya Zhu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-upG P Canellos, J Gollub, D Neuberg, et al.
Cancer|January 15, 1994
Bone marrow dysplasia in patients with newly diagnosed acute myelogenous leukemia does not correlate with history of myelodysplasia or with remission rate and survivalK K Ballen, D G Gilliland, L A Kalish, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Cancer Care and Control as a Human Right: Recognizing Global Oncology as an Academic FieldAlexandru E Eniu, Yehoda M Martei, Edward L Trimble, et al.
JAMA Oncology|August 8, 2020
Applying Lessons Learned From Low-Resource Settings to Prioritize Cancer Care in a PandemicRebecca J DeBoer, Temidayo A Fadelu, Lawrence N Shulman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
A Survey of the National Comprehensive Cancer Network on Approaches Toward Addressing Patients' Transportation InsecurityKrisda H Chaiyachati, Diana Krause, Jessica Sugalski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot studyM A Shipp, D Neuberg, M Janicek, et al.
JAMA Network Open|October 24, 2024
Racial Disparities in Receipt of Guideline-Concordant Care in Older Adults With Early Breast CancerBrenda S Castillo, Taussia Boadi, Xiaoyan Han, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Low-dose total body irradiation and G-CSF without hematopoietic stem cell support in the treatment of relapsed or refractory acute myelogenous leukemia (AML), or AML in second or subsequent remissionL N Shulman, N J Tarbell, E Storen, et al.
Malawi Medical Journal : the Journal of Medical Association of Malawi|December 21, 2013
Biopsy case mix and diagnostic yield at a Malawian central hospitalP Mtonga, L Masamba, D Milner, et al.
Pageof 29